Form4insider filings, from the source

SEC Form 4 · accession 0000932440-16-000521

EAGLE PHARMACEUTICALS, INC. · EGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jay Moorin
10% Owner
Period of report
Nov 7, 2016
Accepted (ET)
Nov 9, 2016 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock $0.001 par valueF3,F4,F1Nov 7, 2016S5,030$75.39D4,126,087IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF5,F1Nov 9, 2016S1,380$75.70D4,124,707IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF6,F1Nov 9, 2016S11,690$76.49D4,113,017IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF7,F1Nov 9, 2016S9,030$77.13D4,103,987IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF8,F1Nov 9, 2016S4,200$78.23D4,099,787IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF9,F1Nov 9, 2016S19,581$79.24D4,080,206IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF10,F1Nov 9, 2016S102,919$80.09D3,977,287IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF2holding———7,977IBy ProQuest Financial LLC
Common Stock $0.001 par valueholding———27,474IBy Jay Moorin through IRA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses